Skip to content
Sign in

REVS · ARCA · ETF

Columbia Research Enhanced Value ETF (REVS) Price, Holdings & Fees

$858.46−0.62%−$5.36End-of-day price as of Oct 9, 2026

Columbia Research Enhanced Value ETF (REVS) closed at $858.46 on Oct 9, 2026, down 0.62% from the previous close of $863.82.

Share price, past year

1Y +11.36%

52-week range $746.33 – $926.89. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$858.46
Sep 30, 2026$867.36
Aug 31, 2026$809.15
Jul 31, 2026$845.47
Jun 30, 2026$887.98
May 29, 2026$912.65
Apr 30, 2026$863.25
Mar 31, 2026$844.70
Feb 27, 2026$811.39
Jan 30, 2026$861.53
Dec 31, 2025$820.87
Nov 28, 2025$808.18
Oct 31, 2025$765.19

Key statistics

Expense ratio
0.19%
as of Oct 31, 2025
Net assets
$333.7M
as of Jul 31, 2026
Holdings
307
as of Jul 31, 2026
52-week range
$746.33 – $926.89

Columbia Research Enhanced Value ETF's expense ratio is 0.19%: $19.00 a year on $10,000 invested.

Holdings

Columbia Research Enhanced Value ETF held 307 investments worth $333.74M as of Jul 31, 2026. Its largest holding was Apple Inc, at 8.00% of the fund.

Columbia Research Enhanced Value ETF largest holdings by share of net assets
#Holding% of fundValue
1Apple Inc8.00%$26.69M
2Microsoft Corp6.81%$22.74M
3Bank of America Corp3.85%$12.86M
4Chevron Corp2.73%$9.10M
5Altria Group Inc2.22%$7.42M
6Citigroup Inc1.90%$6.33M
7Meta Platforms Inc1.79%$5.97M
8Bristol-Myers Squibb Co1.79%$5.96M
9TJX Cos Inc/The1.73%$5.78M
10Cisco Systems Inc1.70%$5.69M
11CVS Health Corp1.68%$5.62M
12Charles Schwab Corp/The1.63%$5.44M
13General Motors Co1.55%$5.16M
14Progressive Corp/The1.30%$4.35M
15NextEra Energy Inc1.22%$4.09M
16Target Corp1.15%$3.85M
17Elevance Health Inc1.12%$3.74M
18Ford Motor Co1.10%$3.69M
19ConocoPhillips1.10%$3.67M
20AbbVie Inc1.09%$3.65M
21Newmont Corp1.07%$3.57M
22Bank of New York Mellon Corp/The1.04%$3.49M
23General Dynamics Corp1.04%$3.47M
24Equinix Inc1.02%$3.42M
25US Bancorp0.97%$3.25M

Top 25 of 307 holdings, as of Jul 31, 2026. Percentages are of the fund's net assets.

What the fund owns

Columbia Research Enhanced Value ETF holdings by asset type
Asset type% of fund
Stocks99.52%
Cash and short-term investments0.41%
Columbia Research Enhanced Value ETF holdings by country, largest 7
Country% of fund
United States97.38%
Ireland1.44%
Bermuda0.54%
United Kingdom0.23%
Jersey0.23%
Puerto Rico0.10%
Netherlands0.01%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to Jul 31, 2026, Columbia Research Enhanced Value ETF's total return was +7.69%, as reported to the SEC.

Columbia Research Enhanced Value ETF monthly total returns
MonthTotal return
Jul 31, 2026+5.40%
Jun 30, 2026−0.13%
May 31, 2026+2.31%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
Columbia Research Enhanced Value ETF
Ticker
REVS
Exchange
ARCA
Fund type
ETF
Trust
Columbia ETF Trust I
SEC series ID
S000066077
SEC CIK
0001551950
Fractional shares
Yes

Recent SEC filings

Shareholder reports and prospectuses are filed by Columbia ETF Trust I, the trust behind Columbia Research Enhanced Value ETF, and cover all of its funds.

Frequently asked questions

What is REVS's price?

Columbia Research Enhanced Value ETF (REVS) closed at $858.46 on Oct 9, 2026, down 0.62% from the previous close of $863.82.

What is REVS's expense ratio?

Columbia Research Enhanced Value ETF's expense ratio is 0.19%: $19.00 a year on $10,000 invested.

What does REVS hold?

Columbia Research Enhanced Value ETF held 307 investments worth $333.74M as of Jul 31, 2026. Its largest holding was Apple Inc, at 8.00% of the fund. Its five largest holdings were Apple Inc, Microsoft Corp, Bank of America Corp, Chevron Corp, Altria Group Inc.

How has REVS performed?

Over the 3 months to Jul 31, 2026, Columbia Research Enhanced Value ETF's total return was +7.69%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jul 31, 2026 (filed Sep 28, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Oct 31, 2025. Prices are generated sample data for development. Data sources and disclosures